Abbott Labs (NYSE: ABT) Sinks 6% After Releasing Q2 Earnings

Abbott stock fell victim to an old earnings season truth: It's all about the guidance

Abbott delivered a solid second quarter but left investors disappointed over the outlook.

Abbott stock dives after company gives gloomy outlook, despite earnings beat

Shares fell nearly 5% in premarket trading....

Abbott lowers sales forecast on diagnostics decline, US funding cuts

Medical device sales remained a bright spot for the company, however, with more than 20% growth in diabetes devices.

Abbott Labs (NYSE: ABT) Sinks 6% After Releasing Q2 Earnings

Live Updates Live Coverage Updates appear automatically as they are published. Abbott Continues to Sink 12:03 pm by Eric Bleeker As of midday, shares of Abbott continue to trend lower. The company’s shares are down about 8%. While Abbott’s shares have plummeted today, they are still up about 7% year-to-date. Growth Rates 10:50 am by Eric Bleeker Here’s a look at Abbott’s growth rates: Metric Q2 25 Q2 2024 YoY Change revenue $11.14B $10.…

Abbott stock fell victim to an old earnings season truth: It’s all about the guidance – DG Verifications & Stats

Shares of Abbott Laboratories fell Thursday after the diversified health-care company delivered a solid second quarter but left investors disappointed with forward guidance. Revenue in the three months ended June 30 rose 7.4% to $11.14 billion, outpacing the $11.07 billion consensus estimate, according to estimates compiled by LSEG. Organic sales , excluding Covid testing results, rose 7.5%, beating the 7.2% estimate, according to FactSet. Adjus…

Abbott reports momentum with Libre CGM business, dual sensor

Abbott says the new Libre app provides a simplified view of data patterns, enabling Freestyle Libre CGM users to better understand the impact of food, activity, and insulin on glucose levels. [Image courtesy of Abbott]Abbott (NYSE:ABT) today reported Street-beating second-quarter results that included significant growth in its Diabetes business. The company’s Medical Device business saw 13.4% growth in reported sales for the quarter. (Read all a…